Market Cap 4.58B
Revenue (ttm) 5.00B
Net Income (ttm) 211.82M
EPS (ttm) N/A
PE Ratio 19.62
Forward PE 18.94
Profit Margin 4.24%
Debt to Equity Ratio 0.86
Volume 1,926,500
Avg Vol 2,184,318
Day's Range N/A - N/A
Shares Out 158.73M
Stochastic %K 70%
Beta 0.88
Analysts Strong Sell
Price Target $34.91

Company Profile

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, includin...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 312 940 2443
Address:
3000 Lakeside Drive, Suite 300N, Bannockburn, United States
PrivateProfiteer
PrivateProfiteer Nov. 15 at 1:09 AM
$OPCH is currently trading at $28.83, showing a moderate bullish sentiment with an RSI of 56.73, indicating potential for further upside but not yet overbought. The price is above both the 30-day moving average (MA30) at $27.54 and the 50-day moving average (MA50) at $27.78, suggesting a positive trend. The recent high of $29.87 is within reach, providing a target for potential gains. Market context indicates a stable environment, with the price maintaining a range between the 60-day high of $29.87 and low of $24.24. Suggested entry point is at $28.90, just above the last close to capture momentum. Set a stop loss at $27.50 to manage risk. Target 1 is $29.50, just below the recent high, and Target 2 is $30.00, providing a psychological barrier. This plan leverages current momentum while allowing for risk management. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:42 AM
$OPCH is currently trading at $28.83, showing a moderate bullish sentiment with an RSI of 56.73, indicating potential for further upside but not yet overbought. The price is above both the 30-day moving average (MA30) at $27.54 and the 50-day moving average (MA50) at $27.78, suggesting a positive trend. The recent high of $29.87 is within reach, providing a target for potential gains. Market context indicates a stable environment, with the price maintaining a range between the 60-day high of $29.87 and low of $24.24. Suggested entry point is at $28.90, just above the last close to capture momentum. Set a stop loss at $27.50 to manage risk. Target 1 is $29.50, just below the recent high, and Target 2 is $30.00, providing a psychological barrier. This plan leverages current momentum while allowing for risk management. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:48 AM
$OPCH is currently trading at $28.65, with an RSI of 52.72 indicating neutral momentum. The stock is above both the 30-day MA of 27.44 and the 50-day MA of 27.78, suggesting a bullish trend in the short to medium term. The recent 60-day high of 29.87 is within reach, providing a potential target. The 60-day low of 24.24 offers a clear support level. Directional bias leans bullish, supported by the price being above key moving averages and the RSI indicating no overbought conditions. Suggested entry point: $28.70, slightly above the last close to confirm momentum. Stop loss: $27.50, below the 30-day MA for risk management. Targets: $29.50 (near the 60D high) and $30.00 (psychological level). Monitor for price action near these levels for potential adjustments. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:24 AM
$OPCH is currently trading at $28.65, with an RSI of 52.72 indicating neutral momentum. The stock is above both the 30-day MA of 27.44 and the 50-day MA of 27.78, suggesting a bullish trend in the short to medium term. The recent 60-day high of 29.87 is within reach, providing a potential target. The 60-day low of 24.24 offers a clear support level. Directional bias leans bullish, supported by the price being above key moving averages and the RSI indicating no overbought conditions. Suggested entry point: $28.70, slightly above the last close to confirm momentum. Stop loss: $27.50, below the 30-day MA for risk management. Targets: $29.50 (near the 60D high) and $30.00 (psychological level). Monitor for price action near these levels for potential adjustments. https://privateprofiteers.com
0 · Reply
ADSlay
ADSlay Nov. 11 at 12:05 AM
$QNCX "Are these reviews even worth it", I asked (you should too) $QNCX will surprise us all Dirk, Charles and Brandon are a formidable trio on a mission. Look how they got us $OPCH partnership. We will be sipping colored-umbrella mai tais by the ocean in 2026. Watch!
1 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 6 at 4:19 PM
0 · Reply
BillionerOfKing
BillionerOfKing Nov. 4 at 3:39 PM
$OPCH Current Stock Price: $27.00 Contracts to trade: $30 OPCH Nov 21 2025 Call Entry: $0.20 Exit: $0.25 ROI: 26% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JarvisFlow
JarvisFlow Nov. 3 at 4:26 PM
TD Cowen has updated their rating for Option Care Health ( $OPCH ) to Hold with a price target of 27.
0 · Reply
Invest2live
Invest2live Oct. 31 at 3:55 PM
$OPCH don’t lose your cheap shares; this has longterm value.
0 · Reply
OptionRunners
OptionRunners Oct. 29 at 5:06 PM
$OPCH Buyer of the November 21st $30/$25 bull risk reversals 3,000 times for $0.65 ahead of earnings tomorrow morning
0 · Reply
Latest News on OPCH
Option Care Health Announces Chief Financial Officer Transition

Aug 20, 2025, 8:45 AM EDT - 3 months ago

Option Care Health Announces Chief Financial Officer Transition


Option Care Health, Inc. (OPCH) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 12:01 PM EDT - 3 months ago

Option Care Health, Inc. (OPCH) Q2 2025 Earnings Call Transcript


Option Care Health, Inc. (OPCH) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 12:29 PM EDT - 7 months ago

Option Care Health, Inc. (OPCH) Q1 2025 Earnings Call Transcript


Option Care Health, Inc. (OPCH) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 1:16 PM EST - 9 months ago

Option Care Health, Inc. (OPCH) Q4 2024 Earnings Call Transcript


Option Care Health: A Deep Dive Into Its Market Dominance

May 31, 2024, 11:50 AM EDT - 1 year ago

Option Care Health: A Deep Dive Into Its Market Dominance


Option Care Health says it is affected by UnitedHealth hack

Mar 14, 2024, 5:04 PM EDT - 1 year ago

Option Care Health says it is affected by UnitedHealth hack

UNH


PrivateProfiteer
PrivateProfiteer Nov. 15 at 1:09 AM
$OPCH is currently trading at $28.83, showing a moderate bullish sentiment with an RSI of 56.73, indicating potential for further upside but not yet overbought. The price is above both the 30-day moving average (MA30) at $27.54 and the 50-day moving average (MA50) at $27.78, suggesting a positive trend. The recent high of $29.87 is within reach, providing a target for potential gains. Market context indicates a stable environment, with the price maintaining a range between the 60-day high of $29.87 and low of $24.24. Suggested entry point is at $28.90, just above the last close to capture momentum. Set a stop loss at $27.50 to manage risk. Target 1 is $29.50, just below the recent high, and Target 2 is $30.00, providing a psychological barrier. This plan leverages current momentum while allowing for risk management. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:42 AM
$OPCH is currently trading at $28.83, showing a moderate bullish sentiment with an RSI of 56.73, indicating potential for further upside but not yet overbought. The price is above both the 30-day moving average (MA30) at $27.54 and the 50-day moving average (MA50) at $27.78, suggesting a positive trend. The recent high of $29.87 is within reach, providing a target for potential gains. Market context indicates a stable environment, with the price maintaining a range between the 60-day high of $29.87 and low of $24.24. Suggested entry point is at $28.90, just above the last close to capture momentum. Set a stop loss at $27.50 to manage risk. Target 1 is $29.50, just below the recent high, and Target 2 is $30.00, providing a psychological barrier. This plan leverages current momentum while allowing for risk management. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:48 AM
$OPCH is currently trading at $28.65, with an RSI of 52.72 indicating neutral momentum. The stock is above both the 30-day MA of 27.44 and the 50-day MA of 27.78, suggesting a bullish trend in the short to medium term. The recent 60-day high of 29.87 is within reach, providing a potential target. The 60-day low of 24.24 offers a clear support level. Directional bias leans bullish, supported by the price being above key moving averages and the RSI indicating no overbought conditions. Suggested entry point: $28.70, slightly above the last close to confirm momentum. Stop loss: $27.50, below the 30-day MA for risk management. Targets: $29.50 (near the 60D high) and $30.00 (psychological level). Monitor for price action near these levels for potential adjustments. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:24 AM
$OPCH is currently trading at $28.65, with an RSI of 52.72 indicating neutral momentum. The stock is above both the 30-day MA of 27.44 and the 50-day MA of 27.78, suggesting a bullish trend in the short to medium term. The recent 60-day high of 29.87 is within reach, providing a potential target. The 60-day low of 24.24 offers a clear support level. Directional bias leans bullish, supported by the price being above key moving averages and the RSI indicating no overbought conditions. Suggested entry point: $28.70, slightly above the last close to confirm momentum. Stop loss: $27.50, below the 30-day MA for risk management. Targets: $29.50 (near the 60D high) and $30.00 (psychological level). Monitor for price action near these levels for potential adjustments. https://privateprofiteers.com
0 · Reply
ADSlay
ADSlay Nov. 11 at 12:05 AM
$QNCX "Are these reviews even worth it", I asked (you should too) $QNCX will surprise us all Dirk, Charles and Brandon are a formidable trio on a mission. Look how they got us $OPCH partnership. We will be sipping colored-umbrella mai tais by the ocean in 2026. Watch!
1 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 6 at 4:19 PM
0 · Reply
BillionerOfKing
BillionerOfKing Nov. 4 at 3:39 PM
$OPCH Current Stock Price: $27.00 Contracts to trade: $30 OPCH Nov 21 2025 Call Entry: $0.20 Exit: $0.25 ROI: 26% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JarvisFlow
JarvisFlow Nov. 3 at 4:26 PM
TD Cowen has updated their rating for Option Care Health ( $OPCH ) to Hold with a price target of 27.
0 · Reply
Invest2live
Invest2live Oct. 31 at 3:55 PM
$OPCH don’t lose your cheap shares; this has longterm value.
0 · Reply
OptionRunners
OptionRunners Oct. 29 at 5:06 PM
$OPCH Buyer of the November 21st $30/$25 bull risk reversals 3,000 times for $0.65 ahead of earnings tomorrow morning
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 29 at 3:40 PM
$OPCH RSI: 74.04, MACD: 0.0829 Vol: 0.57, MA20: 27.57, MA50: 27.97 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ADSlay
ADSlay Oct. 24 at 4:26 PM
$QNCX there are big 'reputation' costs associated for public companies to be partnering with others. They don't just randomly partner with small companies unless there is moat, especially not with someone like $QNCX who is a turnaround story, pre-revenue, and no proven product. I am sure $OPCH must've agreed to partner only after performing their thorough due-diligence. yes, no one refuses extra revenue coming in, but when you're a responsible $5 billion publicly traded company, you don't just randomly partner with anyone. there is a 'brand' image they've to protect.
0 · Reply
ADSlay
ADSlay Oct. 23 at 5:03 PM
$QNCX Anything can happen in biotech world, but why would a $5 billion company like $OPCH agree to a strategic partnership with a $100 million company like $QNCX? That alone makes $QNCX a great risk:reward opportunity besides being a Ph3 asset that has full Regulatory support from FDA.
2 · Reply
ADSlay
ADSlay Oct. 23 at 1:12 PM
Thanks for sharing. Yes, $QNCX Management regularly updates their presentation and is a great resource for research. Why would a $5 billion company associate with a $100 million company? Think why $OPCH would partner with $QNCX ? When one is such a big company, one doesn't associate with random biotech microcaps with unproven product. Think about it.
1 · Reply
Estimize
Estimize Oct. 22 at 12:06 PM
Wall St is expecting 0.43 EPS for $OPCH Q3 [Reporting 10/30 BMO] http://www.estimize.com/intro/opch?chart=historical&metric_name=eps&utm_co
0 · Reply
nikitatrades
nikitatrades Oct. 17 at 1:34 PM
Morgan Stanley initiates $OPCH at Overweight, seeing the company as the key player to benefit from the shift of infusion care into the home and alternative sites.
0 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 11:55 AM
Morgan Stanley has updated their rating for Option Care Health ( $OPCH ) to Overweight with a price target of 35.
0 · Reply
Invest2live
Invest2live Oct. 8 at 11:28 PM
$HPE 52% already; congrats 🎊 🎉🎈 Checkout $QXO and $OPCH
0 · Reply
BeigeBook
BeigeBook Oct. 5 at 3:47 PM
$OPCH Healthcare technology growth. Testing resistance level. Volume confirmation needed. Sector momentum building.
0 · Reply
JarvisFlow
JarvisFlow Oct. 2 at 2:10 PM
TD Cowen has adjusted their stance on Option Care Health ( $OPCH ), setting the rating to Hold with a target price of 30.
0 · Reply
Estimize
Estimize Sep. 29 at 12:03 PM
Wall St is expecting 0.43 EPS for $OPCH Q3 [Reporting 10/30 BMO] http://www.estimize.com/intro/opch?chart=historical&metric_name=eps&utm_co
0 · Reply
Invest2live
Invest2live Sep. 24 at 4:19 PM
$OPCH excellent value; do your dd and get in.
0 · Reply